Advocacy
79 articles
Tumor Biology Matters
Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.
Research Suggests Twitter as a Powerful Tool to Drive Awareness about Pancreatic Cancer
Research analysis of PancChat shows the power of the Twitter chat to raise awareness about pancreatic cancer.
The Value of Molecular Profiling and Genetic Testing
Gina Harrison underwent molecular profiling of her pancreatic tumor, which led her to a clinical trial. Genetic testing showed her BRCA1 mutation was random.
Rewinding 2025: A Year in Pancreatic Cancer Research
We take a look back at the research developments in 2025: KRAS, earlier detection and screening, vaccines, and clinical trials.
New Pancreatic Cancer Public Service Announcement
Let’s Win and the Elvin Howard Sr. Pancreatic Cancer Advocacy Foundation announce a joint public service announcement in a press release.
ASCO GI Symposium Features a Broad Range of Pancreatic Cancer Research
Researchers at ASCO GI 2024 reported on research in health disparities, KRAS and other genetic mutations, and novel treatments.
A Year in Review: 2020
In March 2020, life as we knew it changed. The way we work, the way we gather, the way we each live our daily lives all felt upended, seemingly overnight. The global pandemic of COVID-19 affected everything, including cancer care and research. COVID-19 brought new risks to cancer patients, whose immune systems are compromised from […]
Living with Pancreatic Cancer as a Long-Term Survivor
Roberta Luna has been fighting pancreatic cancer since 2002, but the disease has been part of her life for much longer. Read about her battle.
Picking the Right Team
Brigitte Régnier found a treatment team that was using an unusual approach of giving chemoradiation before surgery for pancreatic cancer.
Changing Course Midstream
Barbara Green wasn’t happy with her doctors, so she took the advice of her support group, was an advocate for herself, and changed doctors.
New Study Targets Specific BRAF Mutation
One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian.
PRECEDE Trial Sets Survival Rate Goal
Dr. Raymond Wadlow explains how earlier detection of high-risk people is key the PRECEDE trial’s goal to increase pancreatic cancer survival rates.
Twice Facing Pancreatic Cancer
Steven Lewis has faced down pancreatic cancer twice–first with a Whipple, chemo and radiation; then with liver surgery for metastasis.
Advocating For My Own Future
Kay Kays is a long-term survivor of pancreatic cancer who has learned to advocate for herself to get the treatments she needs.
Drama Helps Playwright Tackle Pancreatic Cancer Loss
Playwright Isobel Barrett has turned the tragic loss of her husband into a moving play that is also a tool for pancreatic cancer advocacy.